| 000 | 00926 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250511214051.0 | ||
| 264 | 0 | _c19920108 | |
| 008 | 199201s 0 0 eng d | ||
| 022 | _a0027-8874 | ||
| 024 | 7 |
_a10.1093/jnci/83.21.1523 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHande, K R | |
| 245 | 0 | 0 |
_aDrug monitoring in cancer therapy. _h[electronic resource] |
| 260 |
_bJournal of the National Cancer Institute _cNov 1991 |
||
| 300 |
_a1523-4 p. _bdigital |
||
| 500 | _aPublication Type: Editorial | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aBone Marrow _xdrug effects |
| 650 | 0 | 4 | _aDrug Monitoring |
| 650 | 0 | 4 |
_aEtoposide _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 773 | 0 |
_tJournal of the National Cancer Institute _gvol. 83 _gno. 21 _gp. 1523-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jnci/83.21.1523 _zAvailable from publisher's website |
| 999 |
_c1966932 _d1966932 |
||